Abstract
Step therapy protocols require patients to first fail an alternative cheaper treatment before gaining access to a more expensive drug. Health plans use step therapy protocols to optimize prescribing, but there is a risk that their inappropriate application can impede patients’ access to much needed treatments. We assessed a set of US commercial health plans’ use of step therapy protocols in their specialty drug coverage decisions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
